Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis [5]

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 10, 2006, Pages 1199-1200

  Leypoldt, F ^a   Eichhorn, P ^b   Saager, C ^a   Munchau A ^a   Lewerenz, J ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

AGED; ANAMNESIS; CANCER SURGERY; CASE REPORT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; LONG TERM CARE; MUSCLE STRENGTH; MYELITIS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPASTIC PARAPLEGIA;

AGED; ANTIGENS, NEOPLASM; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYELITIS, TRANSVERSE; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; STEROIDS;

EID: 33749000342     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2005.086140     Document Type: Letter

References (5)

1. Pittock SJ, Lucchinetti CF, Lennon VA. Antineuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53:580-7.
2. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124(Pt 6):1138-48.
3. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40.
4. Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-51.
5. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126(Pt 6):1409-18.